Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Mayo Clinic Laboratories, |
RCV003399306 | SCV007301162 | benign | not specified | 2022-09-06 | criteria provided, single submitter | clinical testing | |
| Unidad de Genómica Garrahan, |
RCV003399306 | SCV004122993 | benign | not specified | 2023-11-14 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 52% of patients studied by a panel of primary immunodeficiencies. Number of patients: 50. Only high quality variants are reported. |
| Genome- |
RCV001658221 | SCV001876621 | benign | Singleton-Merten syndrome 2 | 2021-07-30 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV001520480 | SCV001729588 | benign | not provided | 2026-02-04 | criteria provided, single submitter | clinical testing |